(£) GBP (Default)
  • ($) USD
  • ($) AUD
  • (€) EUR
  • ($) CAD

B7-33 Peptide Vial


Laboratory research has shown B7-33 to have many benefits:

  • Anti-fibrotic properties of B7-33 are powerful.
  • Fibrinolysis can be reduced in acute and chronic conditions.
  • B7-33 research has shown that it may extend the life span of those injured.
  • Potential new treatment for heart failure.
  • Keep cardiac injuries from causing excessive scarring.
  • Vascular disorders may be treated with this peptide.
  • Relaxin-like anti-fibrotic properties are still present in B7-33.
  • Anti-inflammatory, antioxidant, and wound-healing properties are found in this peptide.

463 in stock

First time customer gets 10% discount code = 1storder

B7-33 Peptide Vial 2mg United States

B7-33 peptide is a formed as a single-chain peptide synthesised from H2-relaxin, a naturally occurring essential water-soluble protein. B7-33 retains its sedative properties despite having no effect on cAMP synthesis. However, the stimulation of ERK1/2 phosphorylation by this peptide increases MMP2 synthesis and collagen degradation.

Included in the relaxin protein family are relaxin, insulin-like peptide 3, H3-relaxin, and insulin-like peptide 5.

There have been documented musculoskeletal, cardiovascular, and reproductive effects of insulin-related proteins.

According to United States laboratory research, B7-33 peptide has many benefits, including a reduction in fibrinolysis in acute and chronic diseases. It has also shown promise as a treatment for vascular diseases, including the prevention of cardiac injury-related scarring.

B7-33 Peptide Vial Benefits United States

Anti-inflammatory and wound healing qualities.

Relaxin receptors have multiple additional activities. In addition to cAMP, corticotropin-releasing factor (CRF), insulin-like peptides, and GLP-1, orexin and GLP-1 can also activate these receptors.

It has been demonstrated that activators possess anti-inflammatory, antioxidative, and wound-healing effects. Following these discoveries, Relaxin became the primary ligand for these receptors. In addition, these substances have anti-fibrotic effects.

According to United States research, Relaxin is a vasodilator, a stimulant of blood vessel development, and an antihypertensive. Due to these roles, Relaxin possesses potent anti-fibrotic capabilities and is being studied as a potential treatment for acute heart failure and other fibrotic illnesses.

Reduction of Scar Tissue

After cardiac damage, United States B7-33 Peptide has been demonstrated to minimise excessive scar tissue production. It has also shown promise in treating vascular diseases and preeclampsia in pregnancy.

Decreased fibrosis

B7-33 possesses strong anti-fibrotic effects. Therefore, fibrosis reduction is a major area of study interest for acute and chronic disorders such as heart failure, lung inflammation, and renal disease.

For the first time, United States B7-33 peptide can be used to treat heart failure in animals, resulting in a longer survival after injury and improved quality of life.

There is also the option United States to buy B7-33 Nasal Spray and B7-33 Pre Mixed Pen.





B7-33 HPLC Certificates

Disclaimer: We do not supply sarms or peptides to any individual under the age of 21. You must be a licensed and qualified healthcare practitioner. Our team of dedicated professionals are committed to providing an extensive range of products used ONLY in the process of laboratory research by responsible trained and professional individuals. All products listed on this website (direct-sarms.com) and provided through Direct Sarms are intended for laboratory research purposes only. The products listed on this website are NOT for human or animal consumption or ingestion of any kind.

Additional information

Weight 0.01 kg
Dimensions 1 × 1 × 1 cm

2mg vial, Kit_2mg vial, 10ml bac water, syringes